Linfang Li

453 total citations
22 papers, 382 citations indexed

About

Linfang Li is a scholar working on Genetics, Molecular Biology and Biotechnology. According to data from OpenAlex, Linfang Li has authored 22 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 12 papers in Molecular Biology and 7 papers in Biotechnology. Recurrent topics in Linfang Li's work include Virus-based gene therapy research (14 papers), Cancer Research and Treatments (7 papers) and CAR-T cell therapy research (5 papers). Linfang Li is often cited by papers focused on Virus-based gene therapy research (14 papers), Cancer Research and Treatments (7 papers) and CAR-T cell therapy research (5 papers). Linfang Li collaborates with scholars based in China, Sweden and United States. Linfang Li's co-authors include Qijun Qian, Huajun Jin, Mengchao Wu, Changqing Su, Hongping Wu, Yao Huang, Xinyuan Liu, Chengliang Zhou, Xinnan Wang and Jianzhang Zhao and has published in prestigious journals such as PLoS ONE, Chemical Communications and Cancer Letters.

In The Last Decade

Linfang Li

20 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linfang Li China 12 218 159 116 77 49 22 382
Jia Ding China 11 221 1.0× 35 0.2× 114 1.0× 56 0.7× 33 0.7× 35 442
Hadi Al Shamaileh Australia 9 401 1.8× 28 0.2× 117 1.0× 101 1.3× 26 0.5× 9 522
Lan Chen China 10 307 1.4× 53 0.3× 69 0.6× 59 0.8× 16 0.3× 19 448
Katarzyna Zabielska-Koczywąs Poland 12 109 0.5× 99 0.6× 59 0.5× 29 0.4× 27 0.6× 21 352
Hiromichi Kawasaki Japan 10 148 0.7× 26 0.2× 63 0.5× 110 1.4× 73 1.5× 23 327
L. Chen China 8 252 1.2× 159 1.0× 36 0.3× 21 0.3× 15 0.3× 12 366
Jiann-Shiun Lai Taiwan 9 293 1.3× 70 0.4× 80 0.7× 47 0.6× 110 2.2× 16 474
Suzanne Dowson United Kingdom 7 170 0.8× 94 0.6× 177 1.5× 59 0.8× 100 2.0× 11 348
Ginette Balboni France 13 136 0.6× 235 1.5× 180 1.6× 28 0.4× 36 0.7× 17 459
Indi P. Joore Netherlands 4 282 1.3× 75 0.5× 92 0.8× 27 0.4× 25 0.5× 5 416

Countries citing papers authored by Linfang Li

Since Specialization
Citations

This map shows the geographic impact of Linfang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linfang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linfang Li more than expected).

Fields of papers citing papers by Linfang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linfang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linfang Li. The network helps show where Linfang Li may publish in the future.

Co-authorship network of co-authors of Linfang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Linfang Li. A scholar is included among the top collaborators of Linfang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linfang Li. Linfang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Yuqing, Hong Chen, Wei Li, et al.. (2025). Harnessing EVs-ncRNA for Lung Cancer: From Oncogenic Pathways to Novel Diagnostic and Therapeutic Strategies. International Journal of Nanomedicine. Volume 20. 9031–9054. 1 indexed citations
2.
Li, Linfang, et al.. (2024). MK-0608 inhibits in vitro and in vivo RNA replication of infectious pancreatic necrosis virus. Fish & Shellfish Immunology. 151. 109732–109732.
4.
Li, Linfang, Xiuqing Huang, Tao Shen, et al.. (2021). Bone marrow macrophage‐derived exosomal miR‐143‐5p contributes to insulin resistance in hepatocytes by repressing MKP5. Cell Proliferation. 54(12). e13140–e13140. 23 indexed citations
5.
Wang, Shuyue, Linfang Li, Xiehui Chen, et al.. (2018). miR‑338‑3p mediates gluconeogenesis via targeting of PP4R1 in hepatocytes. Molecular Medicine Reports. 18(4). 4129–4137. 11 indexed citations
6.
Li, Linfang, Xue Zhang, Xinnan Wang, et al.. (2018). CTAB-triggered Ag aggregates for reproducible SERS analysis of urinary polycyclic aromatic hydrocarbon metabolites. Chemical Communications. 55(15). 2146–2149. 41 indexed citations
7.
Ye, Zhenlong, Pinyi Liu, Yao Huang, et al.. (2017). 11R-P53 and GM-CSF Expressing Oncolytic Adenovirus Target Cancer Stem Cells with Enhanced Synergistic Activity. Journal of Cancer. 8(2). 199–206. 9 indexed citations
8.
Zhou, Jiao, Jinlan Li, Yan Chang, et al.. (2016). Synergistic antitumor activity of triple-regulated oncolytic adenovirus with VSTM1 and daunorubicin in leukemic cells. APOPTOSIS. 21(10). 1179–1190. 10 indexed citations
9.
Ye, Zhenlong, Yao Huang, Linfang Li, et al.. (2015). Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma. Acta Pharmacologica Sinica. 36(10). 1237–1245. 37 indexed citations
10.
Wang, Jinghan, Yong Yu, Zi Yan, et al.. (2013). Anticancer activity of oncolytic adenoviruses carrying p53 is augmented by 11R in gallbladder cancer cell lines in vitro and in vivo. Oncology Reports. 30(2). 833–841. 9 indexed citations
11.
Li, Linfang, Shijia Liu, Xi Liu, et al.. (2012). Identification of quantitative trait loci for seed storability in rice (Oryza sativa L.). Plant Breeding. 131(6). 739–743. 31 indexed citations
13.
Jin, Huajun, Jiahe Yang, Xilin Wang, et al.. (2011). Use of MicroRNA Let-7 to Control the Replication Specificity of Oncolytic Adenovirus in Hepatocellular Carcinoma Cells. PLoS ONE. 6(7). e21307–e21307. 47 indexed citations
14.
He, Xiaoping, Jia Liu, Chunyan Yang, et al.. (2010). 5/35 Fiber-Modified Conditionally Replicative Adenovirus Armed with p53 Shows Increased Tumor-Suppressing Capacity to Breast Cancer Cells. Human Gene Therapy. 22(3). 283–292. 29 indexed citations
15.
Xie, Min, Yan Chang, Yao Zhang, et al.. (2010). [Synergistic killing effect of the conditionally replicating adenoviruses carrying programmed cell death 5 gene and etoposide on K562 cells].. PubMed. 18(6). 1435–9. 1 indexed citations
16.
Xie, Min, Yan Chang, Qijun Qian, et al.. (2009). A novel triple-regulated oncolytic adenovirus carrying PDCD5 gene exerts potent antitumor efficacy on common human leukemic cell lines. APOPTOSIS. 14(9). 1086–1094. 19 indexed citations
17.
Lin, Chen, Dongfeng Chen, Manli Na, et al.. (2009). Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells. Cancer Letters. 284(2). 141–148. 19 indexed citations
18.
He, Xiaoping, Yao Huang, Lin Chen, et al.. (2009). E2F Promoter-Regulated Oncolytic Adenovirus with p16 Gene Induces Cell Apoptosis and Exerts Antitumor Effect on Gastric Cancer. Digestive Diseases and Sciences. 54(7). 1606–1606. 3 indexed citations
19.
Su, Changqing, Manli Na, Jie Chen, et al.. (2008). Gene-Viral Cancer Therapy Using Dual-Regulated Oncolytic Adenovirus with Antiangiogenesis Gene for Increased Efficacy. Molecular Cancer Research. 6(4). 568–575. 25 indexed citations
20.
Jiang, Minghong, Qin Yang, Yuemin Li, et al.. (2004). [Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene].. PubMed. 84(14). 1147–51. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026